2C Tech Corporation, Inc.
Innovative Nanotechnology

Sixteen million Americans suffer from various ocular diseases, such as retinitis pigmentosa, retinal detachment, diabetic retinopathy, and macular degeneration, which ultimately lead to diminished sight and eventually blindness.  The number of such people is growing rapidly as the age of the general population increases.

2C Tech Corporation, Inc., a Colorado-based biotech company, is developing a medical device based on nanotechnology. The result of this development effort is the unique, patent pending SeeQ device involving intraocularly delivered photoactive nanoparticles, particles which convert light to electrical energy, similar to a conventional solar cell but on a sub-cellular scale.